Details of the Drug Reposition

General Information of This Drug (ID: DMAP58Y)

Drug Name
Peginterferon alfa-2b   DMAP58Y
Synonyms PegIntron; Peginterferon alfa-2b (INN); Peginterferon alfa-2b (generical recombination); Peginterferon alfa-2b (generical recombination) (JAN)
Therapeutic Class
Antiviral Agents

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Leukemia DISNAKFL N.A. Approved [1]
Liver cirrhosis DIS4G1GX DB93.1 Approved [2]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hepatitis C virus infection DISQ0M8R 1E51.1 Discontinued in Phase 2 [3]
------------------------------------------------------------------------------------

References

1 Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study. Lancet Haematol. 2020 Mar;7(3):e196-e208.
2 Hepatitis B therapy. Nat Rev Gastroenterol Hepatol. 2011 May;8(5):275-84.
3 A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma